DLCO declined earliest, falling measurably about 10 years before the defined onset. By five years before onset, DLCO had ...
The dipeptidyl peptidase-1 (DPP1) inhibitor brensocatib became the first licensed therapy for bronchiectasis in the USA and Europe in 2025,1 based on the phase 3 ASPEN trial showing an approximate 20% ...
In idiopathic pulmonary fibrosis (IPF), the trajectory of declining lung function and clinical worsening was less drastic with the use of inhaled treprostinil (Tyvaso), the placeb ...
Aging is associated with increased risk for nearly every lung disease, including acute conditions like pneumonia and chronic diseases like chronic obstructive pulmonary disease, idiopathic pulmonary ...
Background Pulmonary fibrosis (PF) caused by interstitial lung diseases (ILDs) affects up to 0.1% of the global population. There is growing global interest in PF, evident from a nearly threefold ...
Nearly 1 in 3 patients with connective tissue disease-associated interstitial lung disease will develop progressive pulmonary fibrosis.
Residual lung abnormalities were consistent with elevated epithelial injury biomarkers, profibrotic signaling. HealthDay News — Elevated epithelial injury biomarkers and profibrotic signaling are seen ...
A patient with double lung failure survived for two days without both organs after surgeons used an artificial system to replace their function until a transplant became possible. In a report ...
Humans can't live without lungs, but Ankit Bharat's patient did for 48 hours. Reporting in the journal Med, surgeons describe how they removed a patient's infected lungs and built "artificial lungs" ...
In 2023 thoracic surgeon Ankit Bharat was working at Northwestern Memorial Hospital when he was drafted to help a 33-year-old influenza patient who was on the verge of death. Bharat recalls that the ...
Abstract: Self supervised learning is emerging very fastly in computer vision tasks, which address the scarcity of annotated medical images. We introduce a self-supervised approach for anomaly ...